Trademark: 97583883
Word
BEXSON
Status
Pending
Status Code
688
Status Date
Tuesday, October 10, 2023
Serial Number
97583883
Mark Type
4000
Filing Date
Thursday, September 8, 2022
Published for Opposition
Tuesday, August 15, 2023

Trademark Owner History
Bexson Biomedical, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
35 providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
45 providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
44 providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
10 wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
42 medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drugy delivery devices therefor

Trademark Events
Apr 9, 2024
Sou Teas Extension Received
Oct 10, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 15, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2023
Published For Opposition
Jul 26, 2023
Notification Of Notice Of Publication E-Mailed
Jul 12, 2023
Approved For Pub - Principal Register
Jul 12, 2023
Examiner's Amendment Entered
Jul 12, 2023
Notification Of Examiners Amendment E-Mailed
Jul 12, 2023
Examiners Amendment E-Mailed
Jul 12, 2023
Examiners Amendment -Written
Jul 11, 2023
Notification Of Final Refusal Emailed
Jul 11, 2023
Final Refusal E-Mailed
Jul 11, 2023
Final Refusal Written
Jul 11, 2023
Teas/Email Correspondence Entered
Jul 10, 2023
Correspondence Received In Law Office
Jul 10, 2023
Teas Response To Office Action Received
Jun 22, 2023
Notification Of Non-Final Action E-Mailed
Jun 22, 2023
Non-Final Action E-Mailed
Jun 22, 2023
Non-Final Action Written
Jun 22, 2023
Assigned To Examiner
Sep 26, 2022
New Application Office Supplied Data Entered
Sep 12, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24